SOPH
SOPHiA Genetics SA

250
Mkt Cap
$295.13M
Volume
69,136.00
52W High
$5.70
52W Low
$2.58
PE Ratio
-3.72
SOPH Fundamentals
Price
$4.35
Prev Close
$4.33
Open
$4.40
50D MA
$4.87
Beta
1.02
Avg. Volume
184,682.69
EPS (Annual)
-$1.17
P/B
6.32
Rev/Employee
$186,195.18
$308.14
Loading...
Loading...
News
all
press releases
SOPHiA GENETICS Q4 Earnings Call Highlights
SOPHiA GENETICS (NASDAQ:SOPH) executives highlighted accelerating commercial momentum, expanding platform capabilities, and improved profitability outlook during the company's fourth-quarter and...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·5d ago
News Placeholder
SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS
SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.20) by...
MarketBeat·5d ago
News Placeholder
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results PR Newswire BOSTON and ROLLE, Switzerland, March 3, 2026 BOSTON...
PR Newswire·5d ago
News Placeholder
A Look at Sophia Genetics's Upcoming Earnings Report
read more...
Benzinga·6d ago
News Placeholder
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference PR Newswire BOSTON and ROLLE, Switzerland...
PR Newswire·11d ago
News Placeholder
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
TEM heads into Q4 earnings with expected 82.8% revenue growth, rising oncology momentum and a premium valuation clouding near-term upside.
Zacks·18d ago
News Placeholder
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3...
PR Newswire·19d ago
News Placeholder
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large increase in short interest in January. As of January 30th, there was short interest totaling 76,808 shares, an increase of...
MarketBeat·21d ago
News Placeholder
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3%
SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totaling 53,042...
MarketBeat·1mo ago
<
1
2
...
>

Latest SOPH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.